Trial Outcomes & Findings for Effect of a Sciatic Block (SNB) Combined With a Continuous Femoral Block (CFNB) on Pain Scores After Knee Arthroplasty (NCT NCT01337115)

NCT ID: NCT01337115

Last Updated: 2012-06-19

Results Overview

Pain scores measured by Visual Analogue Score (VAS) scale at 15-30min after Post anesthesia care unit (PACU) arrival VAS is a 100mm scale to measure pain. 0mm - no pain 100mm - worst possible pain

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

15-30 min after arrival on post anesthesia care unit (PACU)

Results posted on

2012-06-19

Participant Flow

April 2011-February 2012. Consecutive patients for total knee arthroplasty at Orthopedic Department, Centro Hospitalar do Porto

Patients were excluded before randomization if refuse, could not use Visual Analogue Scale (VAS) scale, had contraindications for any of the components of the anesthesia protocol or, anesthesiologist was not expert in peripheral blocks

Participant milestones

Participant milestones
Measure
Continuous Femoral Nerve Block (CFNB)
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
Overall Study
STARTED
25
25
Overall Study
COMPLETED
23
25
Overall Study
NOT COMPLETED
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Continuous Femoral Nerve Block (CFNB)
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
Overall Study
Protocol Violation
2
0

Baseline Characteristics

Effect of a Sciatic Block (SNB) Combined With a Continuous Femoral Block (CFNB) on Pain Scores After Knee Arthroplasty

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Continuous Femoral Nerve Block (CFNB)
n=25 Participants
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
n=25 Participants
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
Total
n=50 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=93 Participants
15 Participants
n=4 Participants
25 Participants
n=27 Participants
Age, Categorical
>=65 years
15 Participants
n=93 Participants
10 Participants
n=4 Participants
25 Participants
n=27 Participants
Age Continuous
68.16 years
STANDARD_DEVIATION 9.83 • n=93 Participants
65.44 years
STANDARD_DEVIATION 8.93 • n=4 Participants
66.8 years
STANDARD_DEVIATION 9.4 • n=27 Participants
Sex: Female, Male
Female
20 Participants
n=93 Participants
16 Participants
n=4 Participants
36 Participants
n=27 Participants
Sex: Female, Male
Male
5 Participants
n=93 Participants
9 Participants
n=4 Participants
14 Participants
n=27 Participants
Region of Enrollment
Portugal
25 participants
n=93 Participants
25 participants
n=4 Participants
50 participants
n=27 Participants

PRIMARY outcome

Timeframe: 15-30 min after arrival on post anesthesia care unit (PACU)

Population: Participants were analyzed in an Intention to treat (ITT) manner. All randomized subjects (25 in each arm) completed the protocol so all were included for analysis as planned.

Pain scores measured by Visual Analogue Score (VAS) scale at 15-30min after Post anesthesia care unit (PACU) arrival VAS is a 100mm scale to measure pain. 0mm - no pain 100mm - worst possible pain

Outcome measures

Outcome measures
Measure
Continuous Femoral Nerve Block (CFNB)
n=25 Participants
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
n=25 Participants
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
Visual Analogue Scores (VAS) - Pain Scores Measured in mm (0-100)
59.4 units on a scale
Standard Deviation 27.2
30.2 units on a scale
Standard Deviation 30.5

PRIMARY outcome

Timeframe: 12h after surgery

Population: All 25 patients in each arm completed the protocol. Analysis was made in an ITT manner.

VAS pain scores are measured by blinded investigators 12h after surgery . VAS scale: 0 - no pain 100 - worst possible pain

Outcome measures

Outcome measures
Measure
Continuous Femoral Nerve Block (CFNB)
n=25 Participants
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
n=25 Participants
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
VAS Results - Pain Measured in mm (0-100)
26.1 units on a scale
Standard Deviation 23.8
9.2 units on a scale
Standard Deviation 14.8

PRIMARY outcome

Timeframe: 24h after surgery

Population: In the CFNB group 2 patients did not complete the protocol. Analysis was made in an ITT manner and Last Observational Carried Forward (LOCF) was the imputation technique used. In the SNB group, all 25 patients completed the protocol

VAS pain scores are measured by blinded investigators 24h after surgery . VAS scale: 0 - no pain 100 - worst possible pain

Outcome measures

Outcome measures
Measure
Continuous Femoral Nerve Block (CFNB)
n=23 Participants
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
n=25 Participants
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
VAS Results - Pain Scores Measured in mm (0-100)
30.13 units on a scale
Standard Deviation 24.97
32.68 units on a scale
Standard Deviation 24.49

SECONDARY outcome

Timeframe: 1 month after surgery

Population: Analysis was performed on Participants available for telephone contact one month after surgery and was made per protocol.

Satisfaction with the anesthesia technique using a categorical scale with three levels: Bad Reasonable Good/Very Good A Fisher's Exact test is made to asses any differences in the distribution of patients in each arm to each level of the categorical scale

Outcome measures

Outcome measures
Measure
Continuous Femoral Nerve Block (CFNB)
n=20 Participants
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in PACU and maintained for 48h
Single Shot Sciatic Nerve Block (SNB)
n=21 Participants
A single shot sciatic nerve block is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block performed in the control group
Satisfaction With Anesthesia Technique in Each Arm of the Study
Bad
0 participants
0 participants
Satisfaction With Anesthesia Technique in Each Arm of the Study
Reasonable
3 participants
2 participants
Satisfaction With Anesthesia Technique in Each Arm of the Study
Good/Very Good
17 participants
11 participants

Adverse Events

Continuous Femoral Nerve Block (CFNB)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Single Shot Sciatic Nerve Block (SNB)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Raul Carvalho

Centro Hospitalar do Porto

Phone: +351226176114

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place